Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy
Opioids are mainly used to treat both acute and chronic pain. Several opioids are
metabolized to some extent by CYP2D6 (codeine, tramadol, hydrocodone, oxycodone, and …
metabolized to some extent by CYP2D6 (codeine, tramadol, hydrocodone, oxycodone, and …
Trends in tramadol: pharmacology, metabolism, and misuse
Tramadol is a unique analgesic medication, available in variety of formulations, with both
monoaminergic reuptake inhibitory and opioid receptor agonist activity increasingly …
monoaminergic reuptake inhibitory and opioid receptor agonist activity increasingly …
Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update
KR Crews, A Gaedigk… - Clinical …, 2014 - Wiley Online Library
Codeine is bioactivated to morphine, a strong opioid agonist, by the hepatic cytochrome
P450 2D6 (CYP2D6); hence, the efficacy and safety of codeine are governed by CYP2D6 …
P450 2D6 (CYP2D6); hence, the efficacy and safety of codeine are governed by CYP2D6 …
Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II
SF Zhou - Clinical pharmacokinetics, 2009 - Springer
Part I of this article discussed the potential functional importance of genetic mutations and
alleles of the human cytochrome P450 2D6 (CYP2D6) gene. The impact of CYP2D6 …
alleles of the human cytochrome P450 2D6 (CYP2D6) gene. The impact of CYP2D6 …
Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects
M Ingelman-Sundberg, SC Sim, A Gomez… - Pharmacology & …, 2007 - Elsevier
The polymorphic nature of the cytochrome P450 (CYP) genes affects individual drug
response and adverse reactions to a great extent. This variation includes copy number …
response and adverse reactions to a great extent. This variation includes copy number …
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Codeine Therapy in the Context of Cytochrome P450 2D6 (CYP2D6) Genotype
KR Crews, A Gaedigk… - Clinical …, 2012 - Wiley Online Library
Codeine is bioactivated to morphine, a strong opioid agonist, by the hepatic cytochrome
P450 2D6 (CYP2D6); hence, the efficacy and safety of codeine as an analgesic are …
P450 2D6 (CYP2D6); hence, the efficacy and safety of codeine as an analgesic are …
Review of opioid pharmacogenetics and considerations for pain management
Opioid analgesics are the standards of care for the treatment of moderate to severe
nociceptive pain, particularly in the setting of cancer and surgery. Their analgesic properties …
nociceptive pain, particularly in the setting of cancer and surgery. Their analgesic properties …
[HTML][HTML] CYP2D6-guided opioid therapy improves pain control in CYP2D6 intermediate and poor metabolizers: a pragmatic clinical trial
Purpose CYP2D6 bioactivates codeine and tramadol, with intermediate and poor
metabolizers (IMs and PMs) expected to have impaired analgesia. This pragmatic proof-of …
metabolizers (IMs and PMs) expected to have impaired analgesia. This pragmatic proof-of …
Tolerance and withdrawal from prolonged opioid use in critically ill children
OBJECTIVE: After prolonged opioid exposure, children develop opioid-induced
hyperalgesia, tolerance, and withdrawal. Strategies for prevention and management should …
hyperalgesia, tolerance, and withdrawal. Strategies for prevention and management should …
Opioids
B KuKanich, AJ Wiese - … and analgesia: The fifth edition of …, 2015 - Wiley Online Library
Opioids are the prototypical analgesics, antitussives, and antidiarrheal drug class. The
opioid receptor system or opioid effects have been identified in numerous animal species …
opioid receptor system or opioid effects have been identified in numerous animal species …